ArticleNeoplasia (New York, N.Y.)2019

Overcoming Resistance to AC0010, a Third Generation of EGFR Inhibitor, by Targeting c-MET and BCL-2.

Wanhong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.